Diagnosis, prognosis, and tre... [Evid Rep Technol Assess (Summ). 2005] - PubMed

loading

Review [IFG and IGT in Europe and America: the present and prospective]. [Nihon Rinsho. 2005]
Review [IFG and IGT in Europe and America: the present and prospective].
Tsujii S, Kuzuya H. Nihon Rinsho. 2005 Feb; 63 Suppl 2:27-33.
Review [Effect of impaired fasting glucose and impaired glucose tolerance on the progression of diabetic macroangiopathy]. [Nihon Rinsho. 2005]
Review [Effect of impaired fasting glucose and impaired glucose tolerance on the progression of diabetic macroangiopathy].
Igarashi M, Tominaga M. Nihon Rinsho. 2005 Feb; 63 Suppl 2:55-60.
Review Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management. [Diab Vasc Dis Res. 2005]
Review Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
Petersen JL, McGuire DK. Diab Vasc Dis Res. 2005 Feb; 2(1):9-15.
Review [Treatment for patients with impaired glucose tolerance]. [Nihon Rinsho. 2005]
Review [Treatment for patients with impaired glucose tolerance].
Tawaramoto K, Kaku K. Nihon Rinsho. 2005 Feb; 63 Suppl 2:423-7.
Review [Primary prevention of diabetes--importance of early diagnosis and interventions in IGT & IFG]. [Nihon Rinsho. 2005]
Review [Primary prevention of diabetes--importance of early diagnosis and interventions in IGT & IFG].
Kawamori R. Nihon Rinsho. 2005 Feb; 63 Suppl 2:49-54.

Improved Insulin Sensitivity during Pioglitazone Treatment Is Associated with Changes in IGF-I and Cortisol Secretion in Type 2 Diabetes and Impaired Glucose Tolerance. [ISRN Endocrinol. 2013]
Improved Insulin Sensitivity during Pioglitazone Treatment Is Associated with Changes in IGF-I and Cortisol Secretion in Type 2 Diabetes and Impaired Glucose Tolerance.
Arnetz L, Rajamand Ekberg N, Höybye C, Brismar K, Alvarsson M. ISRN Endocrinol. 2013; 2013:148497. Epub 2013 Jan 15.
Type II Diabetes Mellitus in Arabic-Speaking Countries. [Int J Endocrinol. 2012]
Type II Diabetes Mellitus in Arabic-Speaking Countries.
Badran M, Laher I. Int J Endocrinol. 2012; 2012:902873. Epub 2012 Jul 18.
Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design. [BMC Health Serv Res. 2012]
Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design.
Cho AH, Killeya-Jones LA, O'Daniel JM, Kawamoto K, Gallagher P, Haga S, Lucas JE, Trujillo GM, Joy SV, Ginsburg GS. BMC Health Serv Res. 2012 Jan 18; 12:16. Epub 2012 Jan 18.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired f...
Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.
Evid Rep Technol Assess (Summ). 2005 Aug ;(128):1-11.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed